Global /United States /Healthcare /Medical Care Facilities /PMHS

Polomar Health Services, Inc.

PMHS

• OTCMKTS: PMHS • Delayed

0.1200USD 0%

As of 13 June 2026, Polomar Health Services, Inc. has a market cap of $3.37M USD, ranking #45806 globally and #5816 in the United States. It ranks #4054 in the Healthcare sector, and #480 in the Medical Care Facilities industry.

Global Rank

45806

Country Rank

5816

Sector Rank

4054

Industry Rank

480

Key Stats

Market Cap

$3.37MUSD

Enterprise Value

$4.35MUSD

Revenue (TTM)

$37.04KUSD

Net Income (TTM)

-$2.43MUSD

PS Ratio

90.9

PB Ratio

0.4

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Terrence Tierney open_in_new

Employees

Founded

2023

Website

polomarsp.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-47%	83%	-85%	-40%	-85%	-69%	-100%	-100%

News

Markets

Exchange	Ticker	Price	Quotes
OTC Markets (OTCMKTS / OTC) MIC: OTCM PRIMARY	PMHS Polomar Health Services Inc ISIN: US8983912069 Shares Out.: Shares Outstanding: 28.053M¹ Shares Float: 15.231M² TV: TradingView: OTC: PMHS SA: Stock Analysis: OTC: PMHS YF: Yahoo Finance: PMHS GF: Google Finance: OTCMKTS: PMHS BA: Barron's: PMHS MS: Morningstar: PINX: PMHS	0.1200 USD	TV: TradingView: OTC: PMHS SA: Stock Analysis: OTC: PMHS YF: Yahoo Finance: PMHS GF: Google Finance: OTCMKTS: PMHS BA: Barron's: PMHS MS: Morningstar: PINX: PMHS

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Polomar Health Services, Inc.

Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin, as well as compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker’s nevus, vitiligo, and other common skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.

Similar Companies

Industry: Medical Care Facilities (United States)

Name	Market Cap (USD) diff.	PE	Country
HCA Healthcare, Inc. NYSE: HCA	$96.73B 3M%	14.9	United States
Labcorp Holdings Inc. NYSE: LH	$21.13B 628K%	24.6	United States
Tenet Healthcare Corp. NYSE: THC	$15.78B 469K%	11.6	United States
Solventum Corp. NYSE: SOLV	$11.53B 342K%	7.5	United States
The Ensign Group, Inc. NASDAQ: ENSG	$10.89B 323K%	31.9	United States
Universal Health Services, Inc. NYSE: UHS	$10.25B 304K%	6.8	United States

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.18B 852.82B AED 7M%	44.1	United Arab Emirates
Fresenius SE & Co. KGaA XETRA: FRE	$26.55B 22.97B EUR 789K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.45B 22.02B EUR 756K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.48B 84.42B SAR 668K%	35.2	Saudi Arabia
IHH Healthcare Bhd. MYX: 5225	$19.14B 77.85B MYR 568K%	37.0	Malaysia
Rede D'Or São Luiz S.A. BVMF: RDOR3	$16.69B 84.79B BRL 496K%	18.1	Brazil

chevron_leftBack